胰岛素里斯普罗中的ProB29的4S化减缓了纤维的形成
Stephanie L Breunig1, Alex M Chapman1, Jeanne LeBon2
1Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California, USA.
The Journal of biological chemistry
|May 4, 2024
概括
化胰岛素变种在糖尿病治疗方面表现有前途. 一个特定的修改,4S-化,显著延迟胰岛素纤维的形成,改善治疗稳定性.
科学领域:
- 生物化学 生物化学
- 蛋白质工程是指蛋白质工程.
- 药理学 药理学是指药理学的学科.
背景情况:
- 再组合胰岛素对于糖尿病管理至关重要.
- 利斯普罗胰岛素是一种快速起作用的变体,改善了血糖控制,但容易变质.
- 蛋白质变性和纤维细胞的形成是蛋白质疗法的重大挑战.
研究的目的:
- 调查非正规氨基酸突变发生在胰岛素利斯普罗稳定性的影响.
- 探索化プロ林残留物在增强胰岛素治疗性质方面的潜力.
- 评估化对胰岛素纤维化和降糖功效的影响.
主要方法:
- 在胰岛素利斯普罗中用4R-罗林,4S-罗林和4,4-二罗林取代ProB29.
- 在糖尿病小鼠中评估降血糖效应.
- 使用循环二元论 (CD) 评估二级结构.
- 研究了六合体解离动力学和纤维细胞形成.
主要成果:
- 三种化利斯普罗品种都有效地降低了糖尿病小鼠的血糖.
- 化变体的二次结构与原生胰岛素lispro相似.
- 4S-化显著延迟了不需要的胰岛素纤维的形成.
- 化变种在稀释后迅速与六合体解离.
结论:
- 非正规的氨基酸突变发生,特别是ProB29的4S化,可以提高像胰岛素这样的蛋白质治疗药物的稳定性.
- 化胰岛素变种显示出对纤维细胞形成的抗性改善,这是胰岛素治疗中的一个关键挑战.
- 这些发现为开发更稳定,更有效的基于蛋白质的药物提供了战略.
相关概念视频
Insulin: Biosynthesis, Chemistry, and Preparation
374
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
374
Dipeptidyl Peptidase 4 Inhibitors
181
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
181
Protein and Protein Structure
79.5K
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme...
A protein's shape is critical to its function. For example, an enzyme...
79.5K
Insulin Formulations: Types and Delivery
191
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
191
Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
Oral Hypoglycemic Agents: Glinides
154
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
154


